Biofrontera Kicks Off US Clinical Study Program for Ameluz®

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/11/2026

1. ORCL
2. ADBE
3. RH
4. SPY
5. CPRT
6. ACVA
7. SEDG
8. PMTS
9. QQQ
10. TENB

Go back to Biofrontera Kicks Off US Clinical Study Program for Ameluz®
(NASDAQ: BFRI) Delayed: 1.58 +0.12 (8.22%)
Previous Close $1.46    52 Week High $ 
Open $1.54    52 Week Low $ 
Day High $1.61    P/E N/A 
Day Low $1.53    EPS $ 
Volume 833,100